CRISPR Therapeutics AG (NASDAQ:CRSP)

107.71
Delayed Data
As of May 07
 -0.13 / -0.12%
Today’s Change
52.30
Today|||52-Week Range
220.20
-29.65%
Year-to-Date
With 1 Cure Behind It, This Breakthrough Biotech Takes Aim at a Bigger Market
May 07 / MotleyFool.com - Paid Partner Content
Will Vertex's Sickle Cell Gambit Sink bluebird bio's Stock?
May 01 / MotleyFool.com - Paid Partner Content
Asset Management Corp Buys Palantir Technologies Inc, CRISPR Therapeutics AG, Desktop Metal ...
May 04 / GuruFocus News - Paid Partner Content
Vertex (VRTX) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Apr 30 / Zacks.com - Paid Partner Content
This Bold Statement by the Vertex CEO Means a New Blockbuster May be Here Soon
May 04 / MotleyFool.com - Paid Partner Content
Have $1,000 to Invest? Buy These 2 Growth Stocks Right Now
Apr 30 / MotleyFool.com - Paid Partner Content
B & T Capital Management DBA Alpha Capital Managem Buys The St. ...
May 03 / GuruFocus News - Paid Partner Content
Here's How Vertex Pharmaceuticals Beat Expectations in Q1
Apr 30 / MotleyFool.com - Paid Partner Content
Forget Penny Stocks: Buy These 2 Stocks Instead
May 01 / MotleyFool.com - Paid Partner Content
Best Biotech Stocks & ETFs for mRNA, Gene Editing
Apr 29 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close107.84
Today’s open110.31
Day’s range107.38 - 114.00
Volume92,204
Average volume (3 months)2,120,311
Market cap$8.2B
Data as of 4:00pm ET, 05/07/2021

Growth & Valuation

Earnings growth (last year)-530.35%
Earnings growth (this year)+91.12%
Earnings growth (next 5 years)-20.63%
Revenue growth (last year)-99.75%
P/E ratioNM
Price/Sales14,043.90
Price/Book4.79

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...+1.60+1.79%
TLRYTilray Inc+2.01+14.20%
FATEFate Therapeutics In...+0.01+0.01%
XLRNAcceleron Pharma Inc-3.69-3.03%
Data as of 7:11pm ET, 05/07/2021

Financials

Next reporting dateAugust 11, 2021
EPS forecast (this quarter)$3.52
Annual revenue (last year)$719.0K
Annual profit (last year)-$348.9M
Net profit margin-48,520.86%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Zug, Zug

Forecasts